Clinical Trials in New York

Showing 19321-19340 of 22,668 trials

D-Cycloserine Augmentation to CBT With Exposure and Response Prevention in Adults and Adolescents With OCD

NCT01172873

This is a single site, open-label, feasibility study of cognitive behavioral therapy with exposure and response prevention (CBT/ERP) adding the augmentation of D-cycloserine (DCS) for adolescents ages 12-17 with Obsessive Compulsive Disorder (OCD) who are partial or non-responders to first line treatments of CBT or pharmacotherapy.

Obsessive Compulsive Disorder

New York State Psychiatric Institute16 participantsStarted Sep 2008

New York, New York, United States

COMPLETEDPhase 3< 1 mile

The Safety and Tolerability of Alpha-1 Modified Process (MP) In Subjects With Alpha-1-antitrypsin (AAT) Deficiency

NCT00301366

The purpose of this clinical study is to assess the safety and tolerability of Alpha-1 MP in adult Alpha1-antitrypsin deficient patients.

Alpha 1-Antitrypsin Deficiency

Grifols Therapeutics LLC38 participantsStarted Jun 2006

Denver, Colorado, United States • Gainesville, Florida, United States • Miami, Florida, United States +7 more locations

D-Cycloserine Augmentation to CBT With Exposure and Response Prevention in Adults and Adolescents With OCD

The Safety and Tolerability of Alpha-1 Modified Process (MP) In Subjects With Alpha-1-antitrypsin (AAT) Deficiency

Find Trials by Condition in New York

Omnifit Hydroxylapatite (HA) Hip Outcomes Study

STARZ-TX2 Clinical Study: Study of Thoracic Aortic Aneurysm Repair With the Zenith TX2 Endovascular Graft

Phosphate Kinetic Modeling 2

Comparing the Effects of Four Types of Electroconvulsive Therapy on Mood and Thinking in People With Depression

Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer

Imaging the Dopamine Systems in Bulimia Nervosa

AZD6244 vs. Capecitabine (Xeloda®) in Patients With Advanced or Metastatic Pancreatic Cancer, Who Have Failed First Line Gemcitabine Therapy

AZD6244 Versus Pemetrexed (Alimta®) in Patients With Non-small Cell Lung Cancer, Who Have Failed One or Two Prior Chemotherapy Regimen

A Pharmacodynamic Study With Ticagrelor in Hispanic Patients

An Investigation of NNC 0151-0000-0000 in Subjects With Systemic Lupus Erythematosus (SLE)

A Study of the Efficacy and Safety of Imatinib Mesylate in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing C-kit Gene

A Study of Pediatric Patients With Attention Deficit/Hyperactivity Disorder

A Phase 2 Study of Interferon Beta-1a (Avonex®) in Ulcerative Colitis

Study of the Effect of Vitamin D as an Add-on Therapy to Corticosteroids in Asthma

The SOX Trial: Compression Stockings to Prevent the Post-Thrombotic Syndrome

Vehicle Controlled Efficacy and Safety Study of Two Dose Regimens of CD07223 1.5% Topical Gel in Impetigo

Characterization of Signs and Symptoms of Participants With and Without Meibomian Gland Dysfunction

Retrograde Delivery of BMAC (Bone Marrow Aspirate Concentrate) for Congestive Heart Failure